Polymyxin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-367

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 63323-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formulae (Pol08 0001 01)

Chemical structure of polymyxin B, showing the molecular differences between polymyxin B1 (with R=CH3) and polymyxin B2 (with R=H), including the peptide and amino acid components and the sulfate salt form.*

FDA Label Image

Principal Display Panel – Carton Label (Pol08 0001 02)

Label for Polymyxin B for Injection, USP, 500,000 units per vial. The label indicates the product is packaged as 10 sterile vials and is labeled by Fresenius Kabi USA, LLC under the Premier ProRx brand.*

FDA Label Image

Principal Display Panel – Vial Label (Pol08 0001 03)

Label for Polymyxin B for Injection, USP, 500,000 units per vial by Fresenius Kabi USA, LLC. The label includes dosage and storage instructions, a warning about neuro- and nephrotoxicity, and information on handling after reconstitution. It also displays the NDC 63323-367-41 and barcode with manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.